Biomedical Innovation Program


The Biomedical Innovation Program (BIP) at OHSU accelerates the delivery of healthcare technologies from academia to the marketplace in order to improve human health. The program supports collaborative translational research that will lead to technology commercialization within 3-5 years.

The BIP cultivates, evaluates, and funds promising translational projects with the objective of moving innovative technologies to clinical application through commercialization. Do you have an idea for a technical innovation to improve patient care?



New for FY 2017 

Track 2: Drug discovery and therapeutics development

This new funding opportunity through the Biomedical Innovation Program is intended for drug discovery platforms and therapeutic technology projects. Examples of responsive application topics include but are not limited to development and validation of drug targets, screening platforms, small molecules, antibodies, vaccines, and biologics. Through this funding mechanism, OCTRI and TTBD intend to support and accelerate creative, interdisciplinary drug discovery and therapeutic development research at OHSU. Project budgets should not exceed $60,000. Projects will typically be supported for a one-year period; predetermined milestones and quantitative metrics of success will be evaluated on a regular basis.

The complete RFA has details about the submission process, eligibility, and application instructions.

Track 1: Device, diagnostics, and software development.

You may read the full 2016 request for applications here.



The OHSU Division of Management is preparing to launch INVENT 2016, an educational program about innovation and entrepreneurship in the health and life sciences. Brendan Rauw, Vice President of TTBD, will deliver the opening keynote on April 6, 2016, at 5:30pm in the CLSB. Visit the INVENT webpage to learn more about the series and to register for the free workshops and lectures.

Watch previous sessions of the INVENT lecture and seminar series here.

Program Contact

Our office is open year-round to offer guidance towards developing your idea for future award cycles, and welcomes any interested parties to contact us at any time. Read more about the program here.

Aditi Martin, Ph.D.
Oregon Clinical and Translational Research Institute
Program Director, Pilot Awards

Jonathan Jubera
Oregon Clinical and Translational Research Institute
Biomedical Innovation Program, Project Manager